Boston Scientific Corp. (BSX)
48.32
+1.48
(+3.15%)
USD |
NYSE |
Aug 31, 16:00
48.38
+0.06
(+0.13%)
After-Hours: 20:00
Boston Scientific Cash from Operations (Annual) : 4.534B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.534B |
| December 31, 2024 | 3.435B |
| December 31, 2023 | 2.503B |
| December 31, 2022 | 1.526B |
| December 31, 2021 | 1.871B |
| December 31, 2020 | 1.508B |
| December 31, 2019 | 1.836B |
| December 31, 2018 | 310.00M |
| December 31, 2017 | 1.426B |
| December 31, 2016 | 972.00M |
| December 31, 2015 | 600.00M |
| December 31, 2014 | 1.269B |
| December 31, 2013 | 1.082B |
| December 31, 2012 | 1.26B |
| December 31, 2011 | 1.008B |
| December 31, 2010 | 325.00M |
| December 31, 2009 | 835.00M |
| Date | Value |
|---|---|
| December 31, 2008 | 1.216B |
| December 31, 2007 | 934.00M |
| December 31, 2006 | 1.845B |
| December 31, 2005 | 903.00M |
| December 31, 2004 | 1.804B |
| December 31, 2003 | 787.00M |
| December 31, 2002 | 736.00M |
| December 31, 2001 | 490.00M |
| December 31, 2000 | 739.00M |
| December 31, 1999 | 727.00M |
| December 31, 1998 | 258.46M |
| December 31, 1997 | 80.49M |
| December 31, 1996 | 134.34M |
| December 31, 1995 | 24.55M |
| December 31, 1994 | 67.78M |
| December 31, 1993 | 65.78M |
| December 31, 1992 | 42.51M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Abbott Laboratories | 9.566B |
| Becton, Dickinson & Co. | 3.43B |
| Penumbra, Inc. | 238.66M |
| Intuitive Surgical, Inc. | 3.030B |
| Stryker Corp. | 5.044B |